Cancer Serum Biobank

The Cancer Serum Biobank is a high-quality collection of serum samples representing 85 malignant and benign diagnoses. It contains more than 23,000 specimens from approximately 16,000 Mayo Clinic patients. Characteristics of the Cancer Serum Biobank include:

• Participants are 47% female, 53% male.
• Control samples include serum from:
  • Healthy patients.
  • Patients with nontumor disease.
• Serum from patients with tumor disease include:
  • Benign.
  • Malignant.
  • Malignant with no evidence of disease.

Scientists looking for cancer biomarkers can find the solution for their research needs with Mayo Clinic's Cancer Serum Biobank. Key aspects of the biobank include:

• Eighty-five malignant and benign conditions, plus normal controls.
• Pretreatment samples.
• Blood serum from 17,000 Mayo Clinic patients.
• Diagnosis and treatment data.
• International Classification of Diseases for Oncology (ICD-O) morphology grade, CPDS stage and status of tumor at time of draw, where applicable.
• Samples collected between 1975 and 1990.
• Superb quality standard.
• Test samples available.
• Approved by the Institutional Review Board.